Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
65 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Duodenal Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Not yet recruiting Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions: Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction
Interventions: Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin
3 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
4 Not yet recruiting Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Conditions: Functional Pancreatic Neuroendocrine Tumor;   Malignant Somatostatinoma;   Merkel Cell Carcinoma;   Metastatic Adrenal Gland Pheochromocytoma;   Metastatic Carcinoid Tumor;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2B;   Neuroendocrine Neoplasm;   Non-Functional Pancreatic Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Adrenal Gland Pheochromocytoma;   Recurrent Merkel Cell Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor;   Stage III Adrenal Cortex Carcinoma;   Stage III Thyroid Gland Medullary Carcinoma;   Stage IIIA Merkel Cell Carcinoma;   Stage IIIB Merkel Cell Carcinoma;   Stage IV Adrenal Cortex Carcinoma;   Stage IV Merkel Cell Carcinoma;   Stage IVA Thyroid Gland Medullary Carcinoma;   Stage IVB Thyroid Gland Medullary Carcinoma;   Stage IVC Thyroid Gland Medullary Carcinoma;   Thymic Carcinoid Tumor;   VIP-Producing Neuroendocrine Tumor;   Well Differentiated Adrenal Cortex Carcinoma;   Zollinger Ellison Syndrome
Interventions: Drug: Capecitabine;   Drug: Temozolomide;   Drug: Veliparib;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
5 Not yet recruiting Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
Condition: Gastric Ulcer
Interventions: Drug: CJ-12420 50 mg QD;   Drug: CJ-12420 100 mg QD;   Drug: Lansoprazole 30 mg QD
6 Recruiting A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
Condition: Gastric Ulcer
Interventions: Drug: BRI-1501;   Drug: Lafutidine;   Drug: Irsogladine maleate
7 Recruiting Domestic Surgical Robot Clinical Study
Condition: Gastric Ulcer With Perforation But Without Obstruction,
Intervention: Procedure: robotic surgery
8 Recruiting Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
Conditions: Gastroduodenal Ulcer;   Marginal Ulcer;   Peptic Ulcer Hemorrhage
Interventions: Drug: Omeprazole High dose;   Drug: Omeprazole Low dose
9 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
10 Not yet recruiting The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Condition: Peptic Ulcer
Interventions: Drug: Ilaprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole
11 Recruiting Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy
Conditions: Gastritis;   Peptic Ulcer;   Dyspepsia
Interventions: Drug: Berberine;   Drug: clarithromycin;   Drug: Bismuth;   Drug: Lansoprazole;   Drug: amoxicillin
12 Not yet recruiting The Oral Microbiota as Reservoir for Systemic Opportunistic Pathogens
Conditions: Peptic Ulcer;   Pulmonary Disease, Chronic Obstructive;   Dental Plaque
Intervention: Procedure: Dental cleaning
13 Recruiting Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Condition: Peptic Ulcer
Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole;   Drug: histamine-2 receptor antagonist group famotidine
14 Recruiting Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
Conditions: Esophageal Adenocarcinoma;   Barrett's Esophagus;   Reflux Esophagitis
Intervention: Drug: Chlorhexidine gluconate
15 Recruiting Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: oral esomeprazole 20 mg twice daily;   Drug: oral esomeprazole 20 mg once daily
16 Not yet recruiting Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
Conditions: Gastric Cancer;   Pancreatic Cancer;   Bile Duct Cancer;   Duodenal Cancer
Interventions: Drug: The marketed product 2-5 MBq/kg 18F-fluorodeoxyglucose;   Device: EnLightTM;   Device: LightPathTM Imaging System
17 Recruiting WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy
Conditions: Peptic Ulcer;   Gastric Cancer;   Esophagus Cancer;   Oesophagitis;   Hypoxia
Interventions: Device: WEI NASAL JET;   Device: Nasopharyngeal airway without jet ventilator
18 Recruiting Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
Condition: Peptic Ulcer Bleeding
Interventions: Device: Supplementary endoscopy with doppler-guided therapy;   Drug: IV. PPI;   Other: Endoscopic treatment at primary endoscopy
19 Recruiting Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
Conditions: Gastric Ulcer,;   Duodenal Ulcer
Intervention: Other: No Intervention
20 Recruiting Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Condition: Peptic Ulcer
Interventions: Drug: histamine-2 receptor antagonist (famotidine);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years